Generic Pharmaceuticals Businesses for Sale and Investment Opportunities

- We are manufacturers of generic pharmaceuticals. - Manufacturing is done by a third party and we sell the products under our brand name. - We give orders to the manufacturers based on the requirement. - We sell our products to 15-20 distributors who further sell them to 3,00-4,000 pharmacies. - Among the competition we hold the number 1 position in market share in the state. - The top hospital & top doctors use & recommend the product. - We do not require too many employees as the manufacturing is done by a third party. - Promoter has 7+ years of experience in the industry. - The business has a food license and a drug license.

- Pharma manufacturing company, located in Nashik. - The plant is in its final stage of commissioning and will focus on the production of small volume parenterals in ampules, vials, PFS, and lyophilized products. - Technical inspection is pending, post which the business can obtain drug manufacturing license to start the manufacturing process. - Will be manufactured on a principle-to-principle and loan license basis for both local and export markets. - The product line includes human injectable products falling under drug categories such as antibiotics, steroids, analgesics etc. - Business model involves manufacturing products under the brand and formulation of other major pharmaceutical companies and supplying them for marketing and distribution. - The business is registered with the Ministry of Corporate Affairs (MCA), holds a Permanent Account Number (PAN), and is registered with the Micro, Small, and Medium Enterprises (MSME).

- Pharmaceutical business located in Dhaka, Bangladesh, has a rich history of 52 years in the industry, having recently been acquired by new management. - The brand, licenses, registrations, client base, and property have been transferred to the new owners. - Was supplying across Bangladesh, the Middle East, and African countries under its own branding. - The business was temporarily closed down three years ago due to personal reasons, but it is now in the process of re-establishing existing contracts and resuming production. - With 43 patents from medical authorities and various licenses including drug manufacturing, IRC, and Export & Import, the company has a strong foundation for pharmaceutical production and distribution. - The pharmaceutical company manufactured a diverse range of drug formulations, including liquid, capsule, tablet, suspension, syrup, injection, aerosol spray & inhaler, injections, bolus, premix powder, premix solutions, and bulk drugs. - Manufactured drug categories include - antibiotics, antibacterials, chemotherapeutics, antiprotozoals, antidiarrhoeal, antidiabetic, antihistamines, NSAIDs, antihypertensives, multivitamins etc. - The company possesses a broad client base, serving wholesalers, pharmacies, hospitals, clinics, and distributors, indicating its reach and potential for growth in both domestic and international markets. - Revenue will be primarily generated through the sale of generic medications, with a focus on cost-effective production and competitive pricing strategies, positioning the business well for market success. - The company is led by experienced professionals with a background in pharmaceutical manufacturing, research, and business management, indicating strong leadership and expertise within the organization. - Had established strong relationships with suppliers of raw materials, regulatory authorities, distribution partners, and healthcare institutions. Have started re-establishing existing contracts and will restart the supply. Will continue to manufacture under the existing brand. - Additionally, the current owners are into manufacturing and supplying medical equipment to hospitals and healthcare facilities, thereby providing an opportunity to establish new contracts.

- Business owner of a drug wholesale business planning to establish a pharmaceutical drug manufacturing plant. - The focus will be on creating a portfolio of drugs under the company's own brand name. - Initially, the manufacturing will concentrate on oral tablets and capsules, with future plans for expansion into other drug categories. - The company aims to supply its products to distributors across West Bengal, Jharkhand, Bihar, and Odisha. - Raw materials for the manufacturing process will be sourced from Ahmedabad and Visakhapatnam. - Will be obtaining drug license and FDA approval once the business launches.

- GMP-GLP, an ISO 9001:2015 certified unit can easily get WHO-cGMP within a few months. - Approved products 550+. - The manufacturing capacity is 1.5 million tablets per shift (8 hours). - The raw materials are procured from more than 200 vendors. - We have a huge distribution network that makes our medicines available to our clients across the globe. In these years, we have developed a huge client base and acquired many domestic and international clients. - The company is registered in Vadodara but the plant and machinery are in Baddi.

- Manufacturer of generic oral medicines, based in MP. - Our products include oral syrup and ORS powder. - We manufacture under our own brand, as well as for 1 other pharmaceutical brand. - Have started contracts with 2 more brands, just finalized. - Business is B2B. We supply to 20 to 25 wholesalers, distributors and retailers from Bhopal. - This year due to personal reasons and other commitments, we could not operate at our fullest capacity and hence, significant revenue could not be generated. - There is a huge potential for overall growth expansion on taking up more contracts. - The business has drug license.

- The project is to manufacture and supply tablets to the government of Sri Lanka up to 860mln per annum on a buyback guarantee and cost plus 20% margin. - The company can sell also in the private market which has a 40% profit margin. - Own 9.25-acre land valued at USD 1mln approx. - The license is issued and a government buyback agreement is signed. - The project is in plug and play stage where the investor can mobilize immediately. - Commercial manufacturing can commence in 8 months.

1. WHO-GMP and internationally approved manufacturer of antibiotic cephalosporins tablets and dry syrups. 2. Located in an ideal pollution-free area in Nagpur, India. 3. Employs 20 people and has over 40 approved products. 4. Government tender business, P2P, and loan licensing operations. 5. 90% of products are exported, mainly to Africa. 6. F&D facility and have 10 clients currently. 7. Run rate sales have recently dropped due to the registration process for export. 8. With a manufacturing capacity of 5 lakh tablets per 7 hrs shift.

Business specializing in manufacturing tablets, capsules, and liquids under its own brand name. Business has more than 35 COPP. Facility is built as per WHO norms with all epoxy flooring and panel false ceiling. Business has the latest machines and a fully developed lab. Have valid approvals and quotas from CBN Gwalior. Currently doing domestic sales but registration going on for export to other countries. Medicines are sold to distributors and wholesalers in Himachal Pradesh and surrounding states.